Home > News & reports > Scope newsletters

Scope newsletters

Scope is your insight into everything you need to know about what's going on at the Malaghan Institute.

Bringing you the latest in research highlights, clinical trials, staff achievements, and more, it's a direct line to the life-saving research we're doing thanks to the support from our community.

You can receive a copy of Scope straight to your inbox by joining our mailing list at the bottom of this page.

Scope 82 | Trial results offer hope to Kiwis with incurable blood cancer
Read more
Scope 81 | Cracking the code on the ageing immune system
Read more
Scope 80 | Stopping infections at the door
Read more
Scope 79 | Investigating the impact of dietary fibre on type-2 diabetes
Read more
Scope 78 | Lung cancer immunotherapy collaboration tackling health inequities in Aotearoa
Read more
Scope 77 | Homegrown COVID-19 booster vaccine: Building New Zealand’s biomedical capability
Read more
Scope 76 | Discovery points to skin as 'ground zero' for allergic disease
Read more
Scope 75 | Equal protection for everyone: COVID-19 vaccine clinical study launched
Read more
Scope 74 | Gut health - new frontiers in immunology
Read more
Scope 73 | COVID-19 vaccine alliance formed
Read more
Scope 72 | A return to normal: Clinical trials full steam ahead
Read more
Scope 71
Read more
Scope 70
Read more
Scope 69
Read more
Scope 68
Read more
Scope 67
Read more
Scope 66
Read more
Scope 65
Read more
Scope 64
Read more
Scope 63
Read more
Scope 62
Read more
Scope 61
Read more
Scope 60
Read more
Scope 59
Read more
Scope 58
Read more
Scope 55
Read more
Scope 53
Read more
Scope 51
Read more
Scope 50
Read more
Scope 49
Read more
Scope 48
Read more
Scope 47
Read more
Scope 46
Read more
Scope 45
Read more
Scope 44
Read more
Scope 43
Read more
Scope 42
Read more
Scope 41
Read more
Scope 40
Read more
Scope 39
Read more
Scope 38
Read more
Scope 37
Read more
Scope 36
Read more
Scope 35
Read more
Scope 34
Read more
Scope 32
Read more